Grant

Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)

CountryUnited States
Deadline2027-02-11 (81 days left)
Published2026-10-13
SectorsHealth & life sciences, Research & innovation
SourceGrants.gov (US)

Summary

Funding opportunity RFA-AI-28-024. CFDA: 93.855

The buyer, the value, the full description and the link to the official notice are available with a free account.